2024-04-25  6:39:51 PM Chg. +0.35 Volume Bid6:40:08 PM Ask- Market Capitalization Dividend Y. P/E Ratio
73.25USD +0.48% 129,361
Turnover: 9.47 mill.
73.17Bid Size: 102 -Ask Size: - 107.46 bill.USD - 67.82

Business description

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
 

Management board & Supervisory board

CEO
Michael F. Mahoney
Management board
Daniel J. Brennan, Brad Sorenson, Eric Thépaut, Jeff Mirviss, Jodi Eddy, Joseph M. Fitzgerald, Meghan Scanlon, Scott Olson, Vance R. Brown, Wendy Carruthers, Charlie Attlan, Lance Bates, Rosaleen Burke, Arthur C. Butcher, Michael Jones, Stephen Morse, Mary Beth Moynihan, Dr. Kenneth Stein
Supervisory board
Michael F. Mahoney, Charles J. Dockendorff, David S. Wichmann, Edward J. Ludwig, Ellen Zane, John E. Sununu, Nelda J. Connors, Yoshiaki Fujimori, Jessica L. Mega, Susan E. Morano, David Roux
 

Company data

Name: Boston Scientific Corp.
Address: 300 Boston Scientific Way,Marlborough, Massachusetts 01752-1234, USA
Phone: +1-508-683-4000
Fax: -
E-mail: -
Internet: www.bsci.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: -
IPO date: 1992-05-19

Investor relations

Name: Susan Lisa
IR phone: +1-508-683-5670
IR Fax: +1-508-683-5675
IR e-mail: BSXInvestorRelations@bsci.com

Company calendar

CW 18 | 2024-05-02 General Shareholder Meeting
 

Main Shareholders

Others
 
54.68%
Blackrock Inc.
 
9.39%
Vanguard Group Inc
 
8.35%
FMR, LLC
 
8.05%
Massachusetts Financial Services Co.
 
4.72%
State Street Corporation
 
4.32%
Wellington Management Group, LLP
 
2.71%
Primecap Management Company
 
2.56%
Primecap Management Company
 
1.82%
Others
 
3.40%